Rosa Rodriguez-Monguio
Biographic Data
| ID | 5546217 |
|---|---|
| NAME | Rosa Rodriguez-Monguio |
| GIVEN NAMES | Rosa |
| FAMILY NAME | Rodriguez-Monguio |
| SIGNATURE | RODRIGUEZ-MONGUIO R |
| AFFILIATIONS | a School of Public Health and Health Sciences , University of Massachusetts , Amherst , MA , USA |
| ORCID | 0000-0002-5526-9395 |
| VERIFIED | Yes |
| TOTAL WORKS | 6 |
| TOTAL CITATIONS | 4 |
| AUTHOR COUNT | 6 |
| EDITOR COUNT | 0 |
| FIRST PUBLICATION YEAR | 2009 |
| LATEST PUBLICATION YEAR | 2023 |
| H-INDEX | 1 |
Analysis of the Gene Therapies Authorized by the United States Food and Drug Administration and the European Medicines Agency
BACKGROUND: Gene therapy, altering the genes inside human cells, has recently emerged as an alternative for preventing and treating disease. Concerns have been expressed about the clinical value and the high cost of gene therapies. OBJECTIVE: This study assessed the characteristics of the clinical trials, authorizations, and prices of gene therapies in the United States and the European Union. RESEARCH DESIGN: We collected regulatory information …
The American Public Health Association Endorses Single-Payer Health System Reform
Health care is a human right. Achieving universal health insurance coverage for all US residents requires significant system-wide reform. The most equitable and cost-effective health care system is a public, single-payer (SP) system. The rapid growth in national health expenditures can be addressed through a system that yields net savings over projected trends by eliminating profit and waste. With universal health insurance coverage through SP fi…
Driving and riding under the influence of recent marijuana use: Risk factors among a racially diverse sample of young adults
Driving (DUIM) and riding (RUIM) with a driver under the influence of marijuana increases crash risk. This study assessed risk factors for DUIM and RUIM among ethnically diverse young adults. Randomly selected individuals were surveyed. Multivariable regression was used to assess risk factors associated with DUIM and RUIM. Participants ( N = 335, response rate = 34.9%) were 33.7% White non-Hispanic. Reported DUIM and RUIM was not statistically si…
An Evaluation of Substance Abuse, Mental Health Disorders, and Gambling Correlations: An Opportunity for Early Public Health Interventions
Unemployment, Medicaid provisions, the mental health industry, and suicide
This study examines the association between unemployment, Medicaid provisions, the mental health industry, and adult suicides in nine US northeastern states from 1999 to 2009. Results show that increased unemployment is associated with more Medicaid beneficiaries and higher health care spending per beneficiary with no significant relationship with Medicaid mental health spending. The Medicaid beneficiary rate is positively associated with the num…
Patent life of antiretroviral drugs approved in the US from 1987 to 2007
This study analyzes the effective patent life of antiretroviral (ARV) new molecular entities (NMEs) approved for marketing in the United States (US) between 1987 and 2007. The study includes all NMEs approved during the study period with at least one patent listed in the Orange Book (OB). Drugs discontinued from the market were excluded from the analysis. Data sources are the US Food and Drug Administration (FDA) and the US Patent and Trademark O…
Unemployment, Medicaid provisions, the mental health industry, and suicide
This study examines the association between unemployment, Medicaid provisions, the mental health industry, and adult suicides in nine US northeastern states from 1999 to 2009. Results show that increased unemployment is associated with more Medicaid beneficiaries and higher health care spending per beneficiary with no significant relationship with Medicaid mental health spending. The Medicaid beneficiary rate is positively associated with the num…
Patent life of antiretroviral drugs approved in the US from 1987 to 2007
This study analyzes the effective patent life of antiretroviral (ARV) new molecular entities (NMEs) approved for marketing in the United States (US) between 1987 and 2007. The study includes all NMEs approved during the study period with at least one patent listed in the Orange Book (OB). Drugs discontinued from the market were excluded from the analysis. Data sources are the US Food and Drug Administration (FDA) and the US Patent and Trademark O…
Unemployment, Medicaid provisions, the mental health industry, and suicide
This study examines the association between unemployment, Medicaid provisions, the mental health industry, and adult suicides in nine US northeastern states from 1999 to 2009. Results show that increased unemployment is associated with more Medicaid beneficiaries and higher health care spending per beneficiary with no significant relationship with Medicaid mental health spending. The Medicaid beneficiary rate is positively associated with the num…
An Evaluation of Substance Abuse, Mental Health Disorders, and Gambling Correlations: An Opportunity for Early Public Health Interventions
Driving and riding under the influence of recent marijuana use: Risk factors among a racially diverse sample of young adults
Driving (DUIM) and riding (RUIM) with a driver under the influence of marijuana increases crash risk. This study assessed risk factors for DUIM and RUIM among ethnically diverse young adults. Randomly selected individuals were surveyed. Multivariable regression was used to assess risk factors associated with DUIM and RUIM. Participants ( N = 335, response rate = 34.9%) were 33.7% White non-Hispanic. Reported DUIM and RUIM was not statistically si…
The American Public Health Association Endorses Single-Payer Health System Reform
Health care is a human right. Achieving universal health insurance coverage for all US residents requires significant system-wide reform. The most equitable and cost-effective health care system is a public, single-payer (SP) system. The rapid growth in national health expenditures can be addressed through a system that yields net savings over projected trends by eliminating profit and waste. With universal health insurance coverage through SP fi…
Analysis of the Gene Therapies Authorized by the United States Food and Drug Administration and the European Medicines Agency
BACKGROUND: Gene therapy, altering the genes inside human cells, has recently emerged as an alternative for preventing and treating disease. Concerns have been expressed about the clinical value and the high cost of gene therapies. OBJECTIVE: This study assessed the characteristics of the clinical trials, authorizations, and prices of gene therapies in the United States and the European Union. RESEARCH DESIGN: We collected regulatory information …
Medicine (6 works) · Environmental health (4 works) · Business (3 works) · Public health (3 works) · Drug (2 works) · Economic growth (2 works) · Family medicine (2 works) · Finance (2 works) · Food and drug administration (2 works) · Health care (2 works)